Abstract
Surgical tricuspid valve replacement is performed in a small number of patients with congenital heart disease, in whom a surgical valve plasty has failed. Usually, in tricuspid position, a biological valve prosthesis is chosen. These bioprosthesis undergo natural degeneration. Percutaneous tricuspid valve implantation (PTVI) is an off-label catheter intervention, which may enhance the life span of a bioprosthesis in tricuspid position and, hence, reduce the total number of heart surgeries in a patient’s life.
Original language | English |
---|---|
Title of host publication | Cardiac Catheterization for Congenital Heart Disease |
Subtitle of host publication | From Fetal Life to Adulthood, Second Edition |
Publisher | Springer International Publishing |
Pages | 769-781 |
Number of pages | 13 |
ISBN (Electronic) | 9783030698560 |
ISBN (Print) | 9783030698553 |
DOIs | |
State | Published - 1 Jan 2021 |
Keywords
- Bioprosthesis
- Catheter intervention
- Percutaneous tricuspid valve implantation
- Tricuspid valve replacement